BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Fluoxetine
,
rs6983267
,
PDX1
,
glucose metabolic process
,
Breast Cancer
,
Hypothalamus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
1A(1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for 1A(1
Explore Curated Studies Results
Literature
Most Relevant Literature
Effects of iloperidone on hERG 1A/3.1 heterotetrameric channels.
Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Functio…
Expression of Dopamine Receptor 1A and Cannabinoid Receptor 1 Genes in the Cochlea and Brain after S…
Influence of local strain caused by cycloaddition on the band gap control of functionalized single-w…
Transcription factor OsSNAC1 positively regulates nitrate transporter gene expression in rice.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Efficacy of IMCnyeso in Advanced NY-ESO-1 and/or LAGE-1A Positive Cancers
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in C…
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells …
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-…
A Safety Study in Healthy Volunteers of the Single-Use Autoinjector Containing Placebo of BG9418 Int…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ